Australia Research Antibodies Market Size & Outlook
- Biotechnology
- Antibody Production
- Research Antibodies Market Outlook
- Antibody Production
Global Market
Related Markets
Ask Prism AI anything about the research antibodies market
Get a cited answer from GVR research in seconds: segment shares, growth drivers, regulation and forecast assumptions.
Australia research antibodies market highlights
- The Australia research antibodies market generated a revenue of USD 37.1 million in 2025 and is expected to reach USD 73.9 million by 2033.
- The Australia market is expected to grow at a CAGR of 9.2% from 2026 to 2033.
- In terms of segment, monoclonal antibodies was the largest revenue generating specificity in 2025.
- Monoclonal Antibodies is the most lucrative specificity segment registering the fastest growth during the forecast period.
Research antibodies market data book summary
| Market revenue in 2025 | USD 37.1 million |
| Market revenue in 2033 | USD 73.9 million |
| Growth rate | 9.2% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibodies |
| Fastest growing segment | Monoclonal Antibodies |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Polyclonal Antibodies, Monoclonal Antibodies |
| Key market players worldwide | Abcam PLC, Merck KGaA, Thermo Fisher Scientific Inc, Cell Signaling Technology, PerkinElmer, Becton Dickinson & Co, Bio-Techne Corp, Proteintech Group |
Other key industry trends
- In terms of revenue, Australia accounted for 1.9% of the global research antibodies market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Asia Pacific, China research antibodies market is projected to lead the regional market in terms of revenue in 2033.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 219.6 million by 2033.
Rise in government investments in biotechnology sector is anticipated to boost the market in Australia. This project aims at expanding genomic technology and applied knowledge, facilitating increased life span of Australian citizens by funding new research, technologies, and clinical trials.
In May 2018, the government introduced reforms in its R&D tax initiative, which spared companies their lifetime caps on refunds. This initiative also exempted clinical trials cap on the annual refundable amount, easing regulatory policies for Australian-based companies.
No credit card required*
Publish Date: Jun 22, 2026
Customize the Report
20% free customization
- Include
- Countries, segments, points
- Tailor
- To your product definition
- Extend
- Deeper competitor detail
- Or
- A fully bespoke study
- Turnaround
- 5–10 working days
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Research Antibodies Market Scope
Research Antibodies Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Merck KGaA | View profile | 62,345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | www.emdgroup.com |
| Becton Dickinson & Co | View profile | 73,000 | 1 Becton Drive, Franklin Lakes, NJ, United States, 07417-1880 | www.bd.com |
| Thermo Fisher Scientific Inc | View profile | 122,000 | 168 Third Avenue, Waltham, MA, United States, 02451 | www.thermofisher.com |
| Bio-Techne Corp | View profile | 3,050 | 614 McKinley Place N.E., Minneapolis, MN, United States, 55413 | www.bio-techne.com |
| Abcam PLC | View profile | 1,760 | Discovery Drive, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AX | www.abcam.com |
| PerkinElmer | View profile | 10001+ | Waltham, Massachusetts, United States, North America | www.perkinelmer.com |
| Proteintech Group | View profile | 251-500 | Rosamond, Illinois, United States, North America | www.ptglab.com |
| Cell Signaling Technology | View profile | 501-1000 | Danvers, Massachusetts, United States, North America | www.cellsignal.com |
Australia Research Antibodies Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Research Antibodies Market Outlook will help companies and investors design strategic landscapes.
Monoclonal Antibodies was the largest segment with a revenue share of 63.34% in 2025.
Horizon Databook has segmented the Australia research antibodies market based on polyclonal antibodies, monoclonal antibodies covering the revenue growth of each sub-segment from 2021 to 2033.
Rise in government investments in biotechnology sector is anticipated to boost the market in Australia. This project aims at expanding genomic technology and applied knowledge, facilitating increased life span of Australian citizens by funding new research, technologies, and clinical trials.
In May 2018, the government introduced reforms in its R&D tax initiative, which spared companies their lifetime caps on refunds. This initiative also exempted clinical trials cap on the annual refundable amount, easing regulatory policies for Australian-based companies.
- Australia Research Antibodies Market Specificity Outlook (Revenue, USD Million , 2021-2033)
- Polyclonal Antibodies
- Monoclonal Antibodies
- Australia Research Antibodies Market Product Outlook (Revenue, USD Million , 2021-2033)
- Primary
- Secondary
- Australia Research Antibodies Market Technology Outlook (Revenue, USD Million , 2021-2033)
- Western blotting
- Flow cytometry
- Immunofluorescence
- Immunohistochemistry
- Immunoprecipitation
- ELISA
- Others Technology
- Australia Research Antibodies Market Source Outlook (Revenue, USD Million , 2021-2033)
- Rabbit
- Goat
- Mice
- Others Source
- Australia Research Antibodies Market Applications Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Stem Cells
- Others Applications
- Infectious Diseases
- Immunology
- Neurobiology
- Australia Research Antibodies Market End Use Outlook (Revenue, USD Million , 2021-2033)
- Contract Research Organizations
- Pharma & Biotech Companies
- Academic & Research Institutes
Reasons to subscribe to Research Antibodies Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Research Antibodies Market Outlook databook
- Our clientele includes a mix of Research Antibodies Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia Research Antibodies Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Australia Research Antibodies Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Australia Research Antibodies Market, 2021-2033 (US$M)
Australia research antibodies market statistics, by specificity, 2021-2033 (US$M)
